CEimpact Podcast
The CEimpact Podcast features two shows:
GameChangers Clinical Updates
Precept2Practice
GameChangers Clinical Update Series:
The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/
Precept2Practice
The Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence. New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.
Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!
Check back each week for our latest episodes.
CEimpact Podcast
The Role of ApoB in Cardiovascular Disease
Adequate risk assessment and management are crucial in preventing cardiovascular disease. A recent study examined the correlation between common measures of cholesterol concentration versus the number of apolipoprotein B (apo-B)-containing lipoproteins. In other words, should clinicians use different biomarkers for cardiovascular risk assessment? Cardiology Pharmacist, Lindsay Davis, joins Geoff Wall in this discussion.
The GameChanger
Evidence is emerging to suggest apo-B is a more accurate biomarker of MI risk. While not routinely evaluated, apo-B is a GameChanger in that it can be helpful in determining cardiovascular risk in patients with borderline risk factors.
Show Segments
00:00 – Introductions
03:22 – Apolipoprotein B (apo-B)
05:22 – Biomarkers for Cardiovascular Disease
12:58 – The GameChanger
20:37 – Connecting to Practice
28:49 – Closing Remarks
Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Guest:
Lindsay Davis, PharmD, BCPS, BCCP, TTS, ASH-CHC
Professor, Midwestern University
Lindsay Davis has no relevant financial relationships to discuss.
References and resources:
- Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis Distinguishing Between Particle Concentration, Type, and Content
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE
- Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Redeem your CPE or CME credit
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
- Pharmacists: Get a membership
- Prescribers: Get a membership
Continuing Education Information:
Learning Objectives:
1. Describe the role of apolipoprotein B in cardiovascular management
2. Identify patients that may benefit from apolipoprotein B testing
All relevant financial relationships have been mitigated.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-232-H01-P
Initial release date: 06/20/22
Expiration date: 06/20/2023
Additional CPE & CME details can be found here